Stay updated with breaking news from Nick Fox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Doctors have hailed a new era of medicine after a study showed for the first time that a drug can slow the debilitating symptoms of Alzheimer's.
Phase three clinical trials have shown that lecanemab, made by Tokyo-based Eisai, can halt the declines in memory and thinking among patients in the earliest stages.
Lecanemab was found to slow decline in patients’ memory and thinking.
Lecanemab was found to slow decline in patients’ memory and thinking.
Latest data raises apprehensions about the occurrence of brain enlargement and bleeding in patients